The first stop for professional medicines advice

Guidance

664 results

Applied filters

Bank and agency staff and Patient Group Directions

25 February 2020The below summarises the advice on the use of PGDs by bank and agency staff working within organisations.

Baclofen: informing intrathecal risk assessment

11 August 2022Baclofen products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Azithromycin (oral) for use within sexual health services

5 October 2021SPS PGD template for supply of azithromycin for uncomplicated genital Chlamydia trachomatis, non-gonococcal/non-specific urethritis; Mycoplasma genitalium.
Registration required

Azacitidine: Cytotoxic Drug Stability Monograph

1 September 2020Stability information is essential for the safe aseptic preparation of azacitidine

Avoid prescribing desiccated (natural) thyroid extract

20 January 2022Levothyroxine is the standard of care for treating hypothyroidism. Desiccated or natural thyroid extracts (DTE) are not routinely recommended.

Authorising and preparing to use a PGD

30 July 2024Once a PGD is written, there are steps to be completed before the PGD is used within an organisation.

Authorising Independent Healthcare Provider (IHP) PGDs

21 September 2020Considerations are needed when NHS or local authorities commission services using PGDs from independent healthcare providers.

Auditing Patient Group Directions

14 September 2020SPS have developed a template audit tool to support organisations in auditing aspects of PGD development and use.

Asthma: treatment during pregnancy

6 January 2022Signposting evidence-based information on the treatment of asthma during pregnancy

Assuring Investigational Medicinal Product (IMP) supply

22 September 2022Sponsor pharmacy role regarding the supply assurance of Investigational Medicinal Products (IMPs) in CTIMPs
admin